Total Payments
$27,259
2024 Payments
$5,483
Companies
66
Transactions
1,294
Medicare Patients
1,621
Medicare Billing
$265,958
Payment Breakdown by Category
Food & Beverage$26,669 (97.8%)
Education$590.26 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $26,669 | 1,281 | 97.8% |
| Education | $590.26 | 13 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,646 | 215 | $0 (2024) |
| ViiV Healthcare Company | $2,566 | 96 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,324 | 134 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,005 | 100 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,896 | 71 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,190 | 57 | $0 (2024) |
| Astellas Pharma US Inc | $1,056 | 38 | $0 (2024) |
| ABBVIE INC. | $947.10 | 48 | $0 (2024) |
| Allergan, Inc. | $704.11 | 68 | $0 (2020) |
| Janssen Biotech, Inc. | $626.97 | 53 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,483 | 242 | Gilead Sciences, Inc. ($1,252) |
| 2023 | $4,389 | 182 | Gilead Sciences, Inc. ($1,093) |
| 2022 | $3,633 | 159 | Gilead Sciences, Inc. ($826.55) |
| 2021 | $3,334 | 156 | Gilead Sciences, Inc. ($653.04) |
| 2020 | $1,817 | 91 | GlaxoSmithKline, LLC. ($384.03) |
| 2019 | $2,713 | 140 | Gilead Sciences, Inc. ($442.39) |
| 2018 | $2,940 | 145 | Merck Sharp & Dohme Corporation ($628.31) |
| 2017 | $2,951 | 179 | Gilead Sciences Inc ($538.84) |
All Payment Transactions
1,294 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: HIV | ||||||
| 12/26/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $3.02 | General |
| Category: HIV | ||||||
| 12/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2024 | United Therapeutics Corporation | ORENITRAM (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Pulmonary Arterial Hypertension | ||||||
| 12/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $4.66 | General |
| Category: HFCWO | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 12/13/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.85 | General |
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: Immunology | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.90 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.65 | General |
| 12/09/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/06/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardio-pulmonary | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.42 | General |
| 12/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.15 | General |
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: HIV | ||||||
| 12/02/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Respiratory | ||||||
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.40 | General |
| 11/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $10.62 | General |
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 419 | 886 | $252,700 | $67,617 |
| 2022 | 9 | 405 | 1,030 | $282,770 | $71,092 |
| 2021 | 8 | 384 | 903 | $254,260 | $65,699 |
| 2020 | 9 | 413 | 1,083 | $284,191 | $61,549 |
Total Patients
1,621
Total Services
3,902
Medicare Billing
$265,958
Procedure Codes
42
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 224 | $67,200 | $22,757 | 33.9% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 56 | 209 | $62,700 | $10,117 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 40 | 178 | $35,600 | $9,408 | 26.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 55 | $22,275 | $7,823 | 35.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $23,400 | $6,586 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 38 | 38 | $17,670 | $4,121 | 23.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 35 | $10,500 | $2,690 | 25.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 24 | $4,800 | $1,776 | 37.0% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Facility | 2023 | 14 | 51 | $3,060 | $1,005 | 32.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 17 | $3,995 | $1,003 | 25.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 15 | 15 | $1,500 | $331.24 | 22.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 96 | 178 | $53,400 | $17,680 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 53 | 281 | $56,200 | $14,612 | 26.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 58 | 295 | $88,500 | $13,934 | 15.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $26,325 | $7,909 | 30.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 45 | 54 | $21,870 | $7,535 | 34.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 30 | 30 | $13,950 | $3,337 | 23.9% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 29 | 39 | $9,165 | $2,379 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 26 | $7,800 | $2,107 | 27.0% |
| 11045 | Removal of skin and tissue, each additional 20.0 sq cm or less | Facility | 2022 | 15 | 66 | $3,960 | $1,232 | 31.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 16 | 16 | $1,600 | $367.98 | 23.0% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 57 | 278 | $83,400 | $13,746 | 16.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 83 | 131 | $39,300 | $13,582 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 48 | 236 | $47,200 | $12,780 | 27.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 42 | 50 | $20,250 | $7,534 | 37.2% |
About Dr. W Martin, M.D
Dr. W Martin, M.D is a Infectious Disease healthcare provider based in Roseville, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174566566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. W Martin, M.D has received a total of $27,259 in payments from pharmaceutical and medical device companies, with $5,483 received in 2024. These payments were reported across 1,294 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($26,669).
As a Medicare-enrolled provider, Martin has provided services to 1,621 Medicare beneficiaries, totaling 3,902 services with total Medicare billing of $265,958. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Pulmonary Disease
- Location Roseville, CA
- Active Since 06/14/2006
- Last Updated 02/28/2013
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1174566566
Products in Payments
- AVYCAZ (Drug) $1,377
- DOVATO (Drug) $1,142
- TRELEGY ELLIPTA (Drug) $977.19
- STIOLTO RESPIMAT (Drug) $829.99
- NUCALA (Biological) $828.73
- ISENTRESS (Drug) $764.57
- DUPIXENT (Biological) $651.29
- BREZTRI (Drug) $585.81
- APRETUDE (Biological) $568.58
- EGRIFTA (Drug) $553.19
- SYMTUZA (Drug) $518.85
- Arikayce (Drug) $503.26
- GLASSIA (Biological) $450.77
- FASENRA (Biological) $419.47
- DIFICID (Drug) $411.12
- RUKOBIA (Drug) $380.08
- ORENITRAM (Drug) $343.13
- AIRSUPRA (Drug) $335.38
- PIFELTRO (Drug) $306.62
- CUVITRU (Biological) $286.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Roseville
Dr. Javeed Siddiqui, Md, Mph, MD, MPH
Infectious Disease — Payments: $1.7M
Infectious Disease $1.7M
Meryl Perez, M.d, M.D
Infectious Disease — Payments: $2,313
Infectious Disease $2,313
Dr. Ranjani Kalyan, M.d, M.D
Infectious Disease — Payments: $1,217
Infectious Disease $1,217
Dr. Jose Mario D Fontanilla, M.d, M.D
Infectious Disease
Infectious Disease